REQUEST A DEMO
Total
USD $0.00
Search more companies

Shandong Xinhua Pharmaceutical Company Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shandong Xinhua Pharmaceutical Company Limited Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Xinhua Factory , the Predecessor of the Company , wasprincipally engaged in the manufacture & sale of bulkpharmaceuticals, preparations & chemical products. Pursuantto the 1993 Reorganisation , the Company was established on30th Septermber, 1993 as a joint stock limited company inthe PRC with Xinhua Factory as the sole promoter. At thetime of the Company's establishment, its registered capitalwas RMB 27 million divided into 22 million State-ownedshares of RMB 1.00 each, 16720 thousand legal person Sharesof RMB 1.00 each & 33153 thousand employe e shares of RMB1.00 each. In accordance with the 1993 Reorganisation ,productive assets of Xinhua Factory were transferred intothe Company in exchange for the 217440 thousand State-ownedshares issued to Xinhua Factory on the Company'sestablishment. Xinhua Factory retained non-productiveassets such as land & investments in businesses. In June1995, Xinhua underwent a further reorganisation pursuant towhich SXPGC was established on 15th June , 1995 as a whollyState-owned limited liability company pursuant to the PRCCompany Law. All assets, liabilities & businesses of XinhuaFactory were transferred to SXPGC . The Company isprincipally engaged in the development, manufacture & salesof bulk pharmaceuticals, preoparations (such as injections &tablets) and chemical products . The sales of these threetypes of products accounted for 60.0 % B32.1%, and 5.5%respectively of the total turnover of the Company for theyear ended 31st December , 1995 & 57.5%?33.7%, and 7.8%,respectively of the total turnover of the Company for thissix months ended 30th June , 1996 . In 1995 , the Companyproduced approximately 170 types of bulk pharmaceuticals &preparations . The Company was one of the three largestpharmaceutical manufacturers in the PRC in 1995 , both interms of production volume & in terms of turnover.Currently, the Company is the largest producer ofantipyretic & analgesic medicines in the PRC. For the yearended 31st December, 1995, the Company produced in aggregateapproximately 6480 tonnees of antipyretic & analgesicmedicines, representing 18.4%. of the total production ofantipyretic & analgesic medicines in the PRC. The Company'sproducts are sold throughout the PRC & are exported to over40 countries, including Germany, the Netherlands, the UnitedStates, Spain, Japan, and Thailand. The Domestic sales ofthe Company's products accounted for 72.4% of its turnoverfor the year ended 31st December , 1995 and 65.5% of itsturnover for the six months ended 30th June 1996 . TheCompany's H shares were listed on Dec. 31, 1996 on thestock exchange of Hong Kong Limited .

Headquarters
No. 1, Lutai Avenue, High-tech Industrial Development Zone, Zibo City, Shandong Province
Zibo; Shandong; Postal Code: 255086

Contact Details: Purchase the Shandong Xinhua Pharmaceutical Company Limited report to view the information.

Website: http://www.xhzy.com

Basic Information
Total Employees:
Purchase the Shandong Xinhua Pharmaceutical Company Limited report to view the information.
Outstanding Shares:
Purchase the Shandong Xinhua Pharmaceutical Company Limited report to view the information.
Registered Capital:
Purchase the Shandong Xinhua Pharmaceutical Company Limited report to view the information.
Financial Auditors:
Purchase the Shandong Xinhua Pharmaceutical Company Limited report to view the information.
Incorporation Date:
September 30, 1993
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
30.02%
Purchase this report to view the information.
28.33%
Purchase this report to view the information.
5.44%
Purchase this report to view the information.
0.32%
Purchase this report to view the information.
0.2%
Subsidiaries
Shandong Tongxin Pharmaceutical Co., Ltd.
Shandong Xinhua Health Technology Co., Ltd.
Shandong Xinhua Mechanical and Electrical Engineering Co., Ltd.
Company Performance
Financial values in the chart are available after Shandong Xinhua Pharmaceutical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
3.64%
Total operating revenue
3.62%
Operating profit (EBIT)
-10.88%
Net Profit (Loss) for the Period
-11.2%
Total assets
11.39%
Total equity
8.4%
Operating Profit Margin (ROS)
-0.97%
Net Profit Margin
-0.88%
Return on Equity (ROE)
-1.53%
Debt to Equity Ratio
3.93%
Quick Ratio
-0.07%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?